Makuladegeneration i den biomedicinska frontlinjen. Utveckling av biologiska läkemedel, genterapi och stamcellsbehandling ger nytt hopp
Engelsk titel: New treatments in development for age-related macular degeneration
Läs online
Författare:
Kvanta, Anders
;
Lanner, Fredrik
Email: anders.kvanta@sankterik.se
Språk: Swe
Antal referenser: 15
Dokumenttyp:
Översikt
UI-nummer: 16107851
Sammanfattning
Age-related macular degeneration is the most common cause of visual loss in the Western world. The condition has a wet (neovascular) and a dry (degenerative) form. The wet form can be controlled by biological drugs whereas the dry form has no
effective treatment. Treatments in development include next generation biological drugs as well as gene- and stem cell-based therapies. This review summarizes this development and explains why age-related macular degeneration has within a decade
become a disease in the biotechnological forefront.